MedGenesis Therapeutix Inc.

MedGenesis Therapeutix (MedGenesis) is a privately-held biopharmaceutical company committed to developing and commercializing innovative therapeutics to provide life-enhancing treatments to patients with serious neurologic diseases. MedGenesis is a worldwide leader in Convection Enhanced Delivery (CED), a minimally invasive technique that provides for targeted, local treatment of CNS conditions such as Parkinsonís disease, Epilepsy, Brain Cancer and other severely debilitating diseases of the CNS.

© MedGenesis Therapeutix Inc.


What's New

7-Jul-2016: Parkinson's UK & MedGenesis Therapeutix Inc. announce top-line results of Phase 2 GDNF safety and efficacy clinical trial

26-Feb-2015: MedGenesis Named to the Rocket Builders 2015 Ready to Rocket List